Philipp Schwabl Selected Research

Transjugular Intrahepatic Portasystemic Shunt

8/2022	Peripheral versus central venous blood sampling does not influence the assessment of platelet activation in cirrhosis.
1/2021	Placental growth factor levels neither reflect severity of portal hypertension nor portal-hypertensive gastropathy in patients with advanced chronic liver disease.
12/2020	Vitamin A levels reflect disease severity and portal hypertension in patients with cirrhosis.
1/2020	Non-invasive detection of portal hypertension by enhanced liver fibrosis score in patients with different aetiologies of advanced chronic liver disease.
1/2018	ePTFE-TIPS vs repetitive LVP plus albumin for the treatment of refractory ascites in patients with cirrhosis.
1/2018	Transjugular intrahepatic portosystemic shunts (TIPS) for the prevention of variceal re-bleeding - A two decades experience.
12/2017	Re-bleeding rates and survival after early transjugular intrahepatic portosystemic shunt (TIPS) in clinical practice.
9/2017	Non-selective beta-blocker treatment does not impact on kidney function in cirrhotic patients with varices.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Philipp Schwabl Research Topics

Disease

26	Portal Hypertension 09/2022 - 06/2012
25	Liver Diseases (Liver Disease) 08/2022 - 01/2015
23	Fibrosis (Cirrhosis) 04/2022 - 06/2012
15	Liver Cirrhosis (Hepatic Cirrhosis) 11/2022 - 06/2012
8	Ascites 01/2022 - 01/2014
8	Inflammation (Inflammations) 01/2022 - 11/2009
7	Hepatitis C 04/2022 - 03/2015
7	Hepatocellular Carcinoma (Hepatoma) 04/2021 - 01/2018
6	Infections 08/2022 - 01/2014
6	Hemorrhage 01/2022 - 11/2013
3	Coinfection 08/2022 - 01/2014
3	Varicose Veins (Varicose Vein) 04/2022 - 11/2013
3	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 01/2022 - 12/2020
3	Chronic Hepatitis C 01/2021 - 05/2016
2	Alcoholic Liver Diseases (Alcoholic Liver Disease) 08/2022 - 01/2021
2	Non-alcoholic Fatty Liver Disease 08/2022 - 01/2020
2	Thrombosis (Thrombus) 01/2021 - 07/2018
2	Hepatic Encephalopathy 01/2018 - 01/2018
2	Acute Kidney Injury (Acute Renal Failure) 09/2017 - 11/2015
2	Cholestasis 01/2017 - 02/2015
2	Peritonitis 01/2016 - 01/2014
1	Falciparum Malaria (Plasmodium falciparum Malaria) 08/2022
1	Liver Neoplasms (Liver Cancer) 04/2022
1	Anemia 03/2022
1	Thrombocytosis (Thrombocythemia) 03/2022
1	Aneuploidy (Aneuploid) 01/2022
1	Acute-On-Chronic Liver Failure 01/2022
1	Splenomegaly 01/2022
1	Sclerosing Cholangitis 01/2022
1	Malaria 12/2021
1	Reinfection 05/2021

Drug/Important Bio-Agent (IBA)

9	4-(3-chlorophenylsulfanyl)piperidineIBA 01/2022 - 06/2012
6	Biomarkers (Surrogate Marker)IBA 11/2022 - 01/2014
6	InterferonsIBA 04/2022 - 04/2016
5	Antiviral Agents (Antivirals)IBA 01/2022 - 06/2016
4	von Willebrand FactorIBA 08/2022 - 01/2017
4	AlbuminsIBA 04/2022 - 01/2018
3	Propranolol (Inderal)FDA LinkGeneric 01/2022 - 11/2013
3	C-Reactive ProteinIBA 01/2022 - 01/2021
3	Polytetrafluoroethylene (Teflon)FDA Link 01/2018 - 12/2017
2	Complement C3 (C3 Complement)IBA 11/2022 - 01/2014
2	CollagenIBA 11/2022 - 08/2022
2	Proteins (Proteins, Gene)FDA Link 08/2022 - 03/2015
2	lipopolysaccharide-binding proteinIBA 01/2022 - 01/2017
2	Carbon Tetrachloride (Tetrachloromethane)IBA 01/2022 - 01/2017
2	ProcalcitoninIBA 01/2022 - 01/2021
2	Pharmaceutical PreparationsIBA 12/2021 - 01/2017
2	ReninIBA 10/2021 - 01/2017
2	Hydroxyproline (4 Hydroxyproline)IBA 01/2021 - 12/2020
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021 - 11/2019
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 01/2021
2	Vitamin A (Retinol)FDA LinkGeneric 12/2020 - 01/2020
2	riociguatIBA 12/2020 - 01/2018
2	RNA (Ribonucleic Acid)IBA 01/2020 - 04/2016
2	AngiopoietinsIBA 11/2019 - 01/2017
2	Phospholipases (Phospholipase)IBA 01/2019 - 03/2015
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 07/2018 - 01/2015
2	Alanine Transaminase (SGPT)IBA 07/2018 - 01/2015
2	Ribavirin (Virazole)FDA LinkGeneric 03/2018 - 07/2016
2	Transaminases (Aminotransferases)IBA 01/2018 - 02/2015
2	MetalsIBA 01/2018 - 12/2017
2	CreatinineIBA 09/2017 - 11/2015
2	Bile Acids and Salts (Bile Acids)IBA 01/2017 - 01/2017
1	Angiopoietin-2IBA 09/2022
1	Glycoproteins (Glycoprotein)IBA 08/2022
1	alanyl- tyrosyl- prolyl- glycyl- lysyl- phenylalanineIBA 08/2022
1	Adenosine Diphosphate (ADP)IBA 08/2022
1	Epinephrine (Adrenaline)FDA LinkGeneric 08/2022
1	LipopolysaccharidesIBA 08/2022
1	Phosphates (Orthophosphate)IBA 08/2022
1	Thrombin Receptors (Thrombin Receptor)IBA 08/2022
1	Proteinase-Activated ReceptorsIBA 08/2022
1	Toll-Like Receptors (Toll-Like Receptor)IBA 08/2022
1	LipopeptidesIBA 08/2022
1	AntigensIBA 08/2022
1	A-Form DNA (A-DNA)IBA 08/2022
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 04/2022
1	Fetal Proteins (Fetoprotein)IBA 04/2022
1	Choline (Choline Chloride)IBA 01/2022
1	Retroelements (Retrotransposon)IBA 01/2022
1	Thrombin FDA Link 01/2022
1	fibrin fragment D (D-dimer)IBA 01/2022
1	Thioacetamide (Thioacetamid)IBA 01/2022
1	Transcription Factors (Transcription Factor)IBA 12/2021
1	Therapeutic UsesIBA 12/2021
1	LigandsIBA 12/2021
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 12/2021
1	Arginine Vasopressin (Argipressin)IBA 10/2021
1	Hormones (Hormone)IBA 10/2021
1	Natriuretic PeptidesIBA 10/2021
1	AngiotensinsIBA 10/2021
1	AldosteroneIBA 10/2021
1	DesminIBA 01/2021

Therapy/Procedure

15	Therapeutics 04/2022 - 01/2015
8	Transjugular Intrahepatic Portasystemic Shunt 08/2022 - 09/2017
6	Ligation 01/2022 - 11/2013
4	Liver Transplantation 01/2021 - 01/2019
3	Stents 08/2022 - 12/2017
3	Surgical Portasystemic Shunt (Portosystemic Shunt) 01/2018 - 12/2017
1	Splenectomy 03/2022